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A simple, precise and rapid reverse phase UHPLC-PDA method has been developed and validated for
the simultaneous analysis of betamethasone dipropionate (BTM) and retinoic acid (REA) in whitening
cream dosage form. The mixture of betamethasone dipropionate (BTM) and retinoic acid (REA)
was separated on Phenomenex Bonclone 10 C18 (150 mm x 3.9 mm) column. All separations were
performed with a Dionex 3000 Photodiode Array (PDA) detector on 240 nm and 340 nm wavelength,
column temperature at 40oC, and flow rate at 1.0 ml/min. The mobile phase was methanol-acetic
acid 0.1% (85:15) with pH 5. The retention times of BTM and REA were found to be 1.90 and 3.70
minutes, respectively. The method showed good linearity with correlation coefficients of 0.9998 and
1.0000 over the ranges of 5-25 ppm for BTM and 25-200 ppm for REA, respectively. The method has
mean recoveries in the range of 99.37% to 100.94% for all analytes. The developed method can be
used in the routine analysis of BTM and REA in cream formulation, as well as for qualitative analysis
in whitening cosmetic preparations or for quantitative analysis in drug preparations.
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INTRODUCTION
Corticosteroids are highly effective drugs which are
used to treat inflammatory skin conditions, such as
eczema and psoriasis. Side effects of corticosteroids
for long-term use include pustular psoriasis, permanent
skin atrophy and systemic effects, such as hypertension,
contact dermatitis, and diabetes. Depigmentation is a side
effect of topical steroids, thus corticosteroids might be
used as whitening agents in topical medical preparations
illegally sold as cosmetics. Their absorption through the
skin can cause adrenal suppression or even Cushing’s
syndrome. Local side effects of topical corticosteroids
include spreading and worsening of untreated infection;
irreversible thinning of the skin, dermatitis, acne, and
hypertrichosis (Laurence et al., 2011; Desmedt et al.,
2014).
Retinoic acid is an organic acid derived from vitamin A
and it is also known as all-trans retinoic acid. It is a drug
commonly used to treat acne vulgaris. Acne vulgaris is
a common dermatologic problem which could be treated
with systemic or topical drugs (Laurence et al., 2011;
Deswal et al., 2017). However, retinoic acid is forbidden
in Indonesia for all cosmetic preparations (BPOM RI,
2003).

A previous study reported the development and
validation of analytical method for simultaneous analysis
of retinoic acid, hydroquinone and corticosteroid
in cream formulation by high-performance liquid
chromatography (Rahmayuni et al., 2018). However,
there is not yet an analytical method developed for the
simultaneous analysis of combination of betamethasone
dipropionate (BTM) and retinoic acid (REA) in cream.
Based on the fact that these two components are
required to be tested in cream cosmetic preparations
(BPOM RI, 2003), especially in facial skin lightening
creams, this method also can be used for the assay of
those components in drug cream preparations. Thus,
this study aimed to develop a fast, simple, inexpensive,
sensitive and valid method using ultra high-performance
liquid chromatography (UHPLC) for assay of BTM
and REA simultaneously in cream. The proposed
method was validated with validation parameters of
specificity, linearity, limit of detection (LOD) and
limit of quantification (LOQ), precision, and accuracy,
in accordance with USP guidelines (USP 40, 2016),
and later used to analyse creams, both as cosmetic
preparations and drug preparations.
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METHODS
Materials
This study used commercial whitening topical cream
containing both BTM and REA, methanol of liquid
chromatography grade (Merck), acetic acid 98-100%
pro analysis (Merck), double distilled water WIDA
WI UNICAP 1000 ml (PT Widatra Bhakti, Indonesia),
cream base oil-in-water (stearic acid, glycerine,
potassium hydroxide) (PT. Ikapharmindo Putramas
Jakarta, Indonesia), and reference standards of BTM and
REA (PT Unijaya Pratama, Indonesia). The chemical
structures of BTM and REA are shown in Figure 1.

Figure 1. Chemical structures of (a) Betamethasone
dipropionate (BTM) and (b) Retinoic acid (REA)
Instrumentation and Chromatographic Conditions
All separations were performed on the UHPLC Dionex
3000 with Dionex Photodiode Array (PDA) detector.
The data were acquired and analyzed using Chromeleon
software. Chromatographic separation was carried out
on Phenomenex Bonclone 10 C18 (150 mm x 3,9 mm)
column. The mobile phase used was methanol-acetic
acid 0.1% (85:15) with pH 5. Methanol was used as the
solvent and acetic acid 0.1% (in water) was used to set
the mixture to be at pH 5. The dilutions of the standards
in these mixture would help to stabilize the active
substances (BTM and REA) on the instrument (UHPLC).
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Before usage, the mobile phase was filtered through 0.45
μm membrane filter and degassed by ultrasonication. The
flow rate was maintained at 1.0 mL/min with a column
temperature of 40°C. The injection volume was 20 μL,
and the detection was performed at 240 nm for BTM and
340 nm for REA using a PDA detector. Validation of the
method was performed according to the International
Conference on Harmonization (ICH) guidelines (ICH,
1996).
Preparation of Standard Stock Solutions
The standard stock solutions of BTM and REA were
prepared by accurately weighing 12.5 mg of each into a
25 mL volumetric flask. The drugs were then dissolved
in methanol (solvent) until 25 mL. Further dilutions were
made from this stock solution to get the concentrations
of 5, 8, 10, 15, 20, and 25 μg/mL for BTM and of 25, 50,
75, 100, 150 and 200 μg/mL for REA, respectively.
Preparation of Stock Solutions
An aliquot (100 mg) of the matrices (cream base oilin-water) was weighed into 3 mL tubes and dilutions
were made with 10 mL of standard stock solution to get
solutions with 6 concentrations of 5, 8, 10, 15, 20, and 25
μg/mL for BTM and 25, 50, 75, 100, 150 and 200 μg/mL
for REA, respectively.
Method Validation
Specificity
The specificity of this UHPLC method was determined
by complete separation of BTM and REA without any
interference of excipient peak to the BTM and REA
peaks, and by analyzing the resolution (R), tailing factor
(TF) and plate count (PC) parameters of each peak,
besides the purity plots from PDA detector.

Table 1. The final optimized condition for the analysis
Parameter

Condition

Stationary Phase

Phenomenex Bonclone 10 C18 (150 mm X 3,9 mm).

Mobile Phase

A: Methanol; B:Acetic acid 0.1% in water; A:B (85:15); pH 5

Flow Rate

1.0 mL/min

Detection

240 nm, 340 nm

Pump Mode

Isocratic

Injection Volume

20 μL

Run Time

6 min

Column Temperature

40ºC

Retention Time

± 1.90 min for BTM and ± 3.70 min for REA
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Table 2. System suitability test parameters
Parameter

Betamethasone Dipropionate (BTM)

Retinoic Acid (REA)

Retention time

± 1.9 min

± 3.9 min

Theorical plates (N)

2971.6

2622.2

Asymmetry

0.95

0.97

Resolution

3.0121

3.0121

Figure 2. Chromatograms of betamethasone dipropionate (BTM) and
retinoic acid (REA)
Linearity and range
Linearity test was performed with a mixture containing
BTM and REA. The standard solution for BTM and
REA were diluted to concentrations of 25-150 μg/mL
and 25-150 μg/mL, respectively. The sorting and dilution
were performed quantitatively. Then, the solutions
were filtered with a 0.22 μm porous filter membrane
and injected into the UHPLC system. Chromatograms
were recorded. All measurements were repeated three
times for each concentration and calibration curve was
constructed by plotting the peak areas of analyte versus
the corresponding drug concentration (Supandi et al,
2018).
Limits of detection and quantification
The limit of detection (LOD) and limit of quantification
(LOQ) were calculated after the linearity test. The values
were calculated from the standard deviation (SD) of
response and the slope of the curve (S) with the equations:
LOD = 3.3 (SD/S) and LOQ = 10 (SD/S), where SD is
standard deviation of the detector response and S is slope
of the calibration curve (Harmita, 2004).
Precision
The precision of the proposed method was assessed
E-ISSN 2477-0612

by preparing three different sample solutions at low,
medium, and high concentrations, which were freshly
prepared and analyzed. The relative standard deviation
(% RSD) was assessed by analyzing standard drug
solutions within the calibration range. The precision of
the method was expressed as % RSD (AOAC, 2002).
Accuracy
Accuracy was calculated as the difference between
theoretical added amount and the practically achieved
amount. To check the degree of accuracy of the method,
recovery studies were performed in triplicate by standard
addition method at 80%, 100%, and 120%. The known
amount of standard BTM and REA were added to preanalyzed samples and were subjected to the proposed
method (Petrova et al., 2013).
Application for analysis of commercial cream
The validated method was then used for testing cream
samples from an online market. The sample used in this
test was a whitening cream. A portion of the cream was
weighed about 500 mg into the appropriate tube to get
100 μg/ml concentration. The sample was extracted with
methanol with the aid of ultrasonication for 15 minutes,
and then filtered using 0.45 μm porous filter membrane.
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RESULTS AND DISCUSSION
Chromatographic Conditions
A satisfactory separation and good peak symmetry
were obtained in the optimized conditions by using
the described methanol-acetic acid 0.1% (85:15)
with pH 5. The flow rate was 1.0 mL/minutes and
oven temperature for column was set to 40°C. Using
PDA detector, the chromatograms was read with
Chromeleon Chromatography software by using time
wavelength procedure. BTM and REA were measured
at the optimum wavelengths of 240 nm and 340 nm,
respectively (Table 1). The system suitability parameters
for UHPLC chromatogram are as follows (Table 2). The
average retention times for BTM and REA were found to
be 1.90 and 3.70 minutes, respectively (Figure 2).
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Specificity
This UHPLC method was in accordance to the
specificity parameter. The chromatograms of BTM and
REA were completely separated from each other and
without any interference from excipient peak (Figure
2). The resolution (R), plate count (PC), and asymmetry
parameters of each peak also met the requirements,
which were ≥ 2 for R, ≤ 2 for asymmetry and ≥ 2000 for
PC (Table 2) (Bendre & Ghule, 2016).
Linearity and Range
The value of Vxo of each component was ≤ 2.0 and r
value was ≥ 0.9990, which confirmed the good linearity
of this method (Table 3). Linear regression data for
the calibration plots revealed good linear relationships
between response and correlation. The linear regression
equations were y = 0.6388x + 0.6166 for BTM, and y =
0.3151x + 0.1109 for REA (Table 3).

Table 3. Specificity, range, LOD and LOQ parameters
Parameter

Betamethasone Dipropionate (BTM) Retinoic Acid (REA)

Linearity range, μg/ml
Regression equation
r2
r
Slope
Y-intercept
LOD (μg/mL)
LOQ (μg/mL)
Precision (RSD%)

5-25
y = 0.6388x + 0.6166
0.9997
0.9998
0.6388
0.6166
1.28
3.87

25-200
y = 0.3151x + 0.1109
1.0000
1.0000
0.3151
0.1109
8.42
25.51

0.93%

0.50%

Table 4. Accuracy parameter
Concentration (μg/mL)*
BTM

REA

Accuracy (% Recovery)
5
15
25
25
100
200

± 100.38
± 99.37
± 100.00
± 100.94
± 99.87
± 99.98

* Average from three repetitions

Limits of Detection and Quantification
The LOD and the LOQ for this simultaneous analysis
were found to be 1.27 μg/mL and 3.86 μg/mL for BTM,
and 8.41 μg/mL and 25.51 μg/mL for REA, respectively
(Table 3).
Precision
The values of RSD% were found to be 0.93% from BTM

and 0.50% for REA (Table 3). These values indicate that
the repeatability of this method is satisfactory (Huber,
2007).
Accuracy
The recovery values were between 99.37-100.38% for
BTM and 99.87-100.94% for REA, which indicate that
the method is accurate (Table 4).
E-ISSN 2477-0612
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Table 5. Assay of commercial creams
Cream

Containing
BTM *(%)

REA *(%)

A

2.41

0.01

B

0.11

0.11

C

0.25

N.A

D

0.60

3.30

E

0.65

3.53

N.A Not applicable
* Average from three repetitions

Application for Analysis of Commercial Cream
The peaks obtained with PDA detector at 240 and 340
nm for BTM and REA, respectively, from commercial
creams were sharp and well-defined. The measurement
results are presented in Table 5. The result of this study
proves that UHPLC with this method can be used for
analysis of BTM and REA simultaneously in cream
preparations.
CONCLUSION
The mixture of betamethasone dipropionate (BTM) and
retinoic acid (REA) can be separated using UHPLC
method with mobile phase of methanol-acetic acid 0.1%
(85:15) at pH 5, Phenomenex Bonclone 10 C18 (150 mm
x 3.9 mm) column at temperature of 40oC, flow rate at
1.0 ml/min, and Dionex 3000 Photodiode Array (PDA)
detector on 240 nm and 340 nm wavelengths for BTM
and REA, respectively. The proposed UHPLC method is
accurate, precise, sensitive, selective, and rapid for the
simultaneous determination of BTM and REA in a cream
formulation.
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